Last verified: May 2026
What Section 781 Changes
Section 781 of Public Law 119-37 modifies the federal definition of hemp originally established by the 2018 Farm Bill. The 2018 definition was based on delta-9 THC alone ≤ 0.3% by dry weight. Hemp processors discovered that the ≤0.3% delta-9 limit did not constrain other psychoactive cannabinoids, and developed a substantial market in:
- Delta-8 THC — isomerized from CBD; psychoactive at moderate doses.
- Delta-10 THC — another isomer; psychoactive.
- HHC (hexahydrocannabinol) — a hydrogenated cannabinoid; psychoactive.
- THC-O acetate — a synthetic acetate ester; potent psychoactive.
- THCA flower — raw cannabis flower with THCA > 0.3% but delta-9 ≤ 0.3% (THCA decarboxylates to delta-9 THC when smoked or heated).
- High-dose hemp THC beverages and gummies — products containing ≤0.3% delta-9 by dry weight but high absolute milligram THC content per serving (10–100+ mg).
The New Definition
Section 781 redefines federal hemp by a total-THC standard. Total THC = delta-9 THC + 0.877 × THCA (the conversion factor accounts for the molecular weight difference when THCA decarboxylates to delta-9). To be lawful federal hemp under the new standard, cannabis must contain ≤0.3% total THC by dry weight.
Section 781 also imposes a 0.4 mg total THC per finished-product container cap. This cap applies to consumer-facing products like beverages, gummies, and edibles, and effectively eliminates the high-dose hemp THC beverage / edible category. A 10 mg hemp THC gummy — a common gray-market product as of 2025 — would be 25 times the federal cliff cap.
Effective Date and Sector Scale
The effective date is November 12, 2026 — a one-year lookback from signing to permit industry adjustment. The U.S. Hemp Roundtable, an industry trade association, estimates the affected sector at approximately $28 billion in annual U.S. retail sales. The estimate covers smokable THCA flower, hemp-derived Delta-8 / Delta-10 / HHC products, and high-dose hemp THC beverages and edibles.
The sector scale is comparable to the size of the regulated state-cannabis-program sector (which the Cannabis Industry Association estimates at $30+ billion in annual U.S. retail sales). The federal cliff effectively removes the unregulated competitor to the regulated state-cannabis programs.
The HB 445 Stack
For Alabama, the federal cliff stacks with HB 445. The two regulatory layers eliminate substantially overlapping product categories:
- HB 445 (effective July 1, 2025) — bans smokable hemp at the state level, restricts synthetics, caps edibles at 10 mg/serving + 40 mg/package, restricts distribution to ABC-licensed liquor stores.
- Federal cliff (effective November 12, 2026) — redefines federal hemp by total-THC standard, caps finished products at 0.4 mg/container.
The combined effect: Alabama’s hemp-derived intoxicant retail sector will be substantially curtailed by November 12, 2026. The federal cliff makes the underlying products federally unlawful even under the most permissive state regulatory framework.
Industry Response & Litigation Posture
The U.S. Hemp Roundtable, the Cannabis Industry Association, and various hemp trade groups are pursuing several strategies:
- Legislative repeal or extension. Lobbying Congress to repeal Section 781 or extend the effective date. As of May 2026, no repeal or extension legislation has advanced.
- Implementation regulatory comments. USDA implementation rule-making is ongoing. Industry groups are submitting comments to shape the final implementation rules.
- Federal-court challenges. Pre-emptive constitutional challenges to Section 781 are being explored.
- Compliant product reformulation. Hemp processors are developing 0.4 mg / container compliant products to maintain consumer offerings within the new framework.
What This Means for Alabama Patients and Consumers
For Alabama patients who have used hemp-derived Delta-8 or Delta-9 products for symptom management, the federal cliff (combined with HB 445) means the gray-market alternative to the Compassion Act will be substantially less available after November 12, 2026. Practical implications:
- Compassion Act enrollment may grow. Patients who have been using hemp-derived alternatives may pursue Compassion Act enrollment for legitimate symptom management.
- Online interstate purchase may shift. The federal cliff applies nationally; out-of-state online retailers face the same constraints.
- Beverages and edibles will be substantially limited. The 0.4 mg/container cap eliminates high-dose hemp THC beverages and edibles regardless of state-level rules.
- CBD products are largely unaffected. CBD-only products without psychoactive THC content remain compliant under the new federal definition.
What This Means for Alabama Hemp Operators
- Smokable-hemp products (already restricted under HB 445) become federally unlawful November 12, 2026.
- High-dose hemp THC beverages and edibles become federally unlawful regardless of state-level rules.
- Synthetic-hemp products (already restricted under HB 445) remain unlawful under the new federal framework.
- Compliant CBD-only products remain federally and state-lawful.
- 0.4 mg / container compliant products — if industry can develop them — may remain federally lawful but may face state-level restrictions.
The Compassion Act’s Window
The federal cliff timing aligns with the Compassion Act’s operational scaling. Callie’s opened May 4, 2026; CCS of Alabama, GP6 Wellness, and Yellowhammer (if cleared) are expected to open by late 2026. Integrated facilities may follow in 2027. The window between Callie’s opening and the federal cliff is approximately 6 months — potentially a critical period for the regulated medical-cannabis program to capture patients transitioning from the gray-market hemp-derived intoxicant retail.
For in-depth cannabis education, dosing guides, safety information, and research summaries, visit our partner site TryCannabis.org